Cardinal Health Board Wants Opioid Derivative Suit Axed

By Emilie Ruscoe · September 24, 2019, 5:55 PM EDT

The board of directors of pharmaceutical distributor Cardinal Health Inc. has urged an Ohio federal judge to toss an activist shareholder's derivative suit related to the opioid crisis, saying it was...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Motion

Case Information

Case Title

In Re: Cardinal Health, Inc. Derivative Litigation

Case Number

Court

Ohio Southern

Nature of Suit

Stockholders Suits

Date Filed

June 14, 2019

Recent Articles By Emilie

May 15, 2025
Ex-CEO Cops To Conspiracy Charge In $212M Fraud Case
May 14, 2025
Actinium Faces Derivative Suit Over FDA Application Claims
May 13, 2025
Health Co. Elevance Faces Suit Over Post-COVID Costs Claims
April 29, 2025
Acadia Investors Seek Partial Win, Sanction In Healthcare Suit
March 24, 2025
Investors Blame Electrotherapy Co.'s Practices For Stock Drop
January 07, 2025
Obesity Drug Maker Faces Investor Suit Over IPO Disclosures
January 06, 2025
Biotech Co. Revance Faces Suit After Tender Offer Weakens
January 02, 2025
Eye Drug Study Blindsided Pharma Co. Investors, Suit Says
December 16, 2024
Ginkgo Bioworks Investors Get Final OK Of $17.8M Settlement
December 13, 2024
Pharma Co. Brass Face Investor Suit Over Drug Trial Probe